
Blackstone Inc (BX) and Krystal Biotech Inc (KRYS) are experiencing notably elevated options trading volume today, representing 56.5% and 55.2% of their respective average daily trading volumes. Significant activity was observed in BX's November 2025 $170 call options and KRYS's December 2025 $175 put options, indicating focused investor interest in these specific long-dated positions.
Blackstone Inc (BX) and Krystal Biotech Inc (KRYS) are exhibiting notably elevated options trading volumes today, representing 56.5% and 55.2% of their respective average daily trading volumes over the past month. This significant activity, totaling 20,826 contracts for BX and 1,669 for KRYS, points to focused institutional interest in these specific equities. A key observation for BX is the high volume in the November 2025 $170 call option, with 4,890 contracts traded, suggesting a long-term bullish conviction or strategic hedging against upside potential. For KRYS, the December 2025 $175 put option saw 750 contracts change hands, which could indicate a bearish outlook or a desire for downside protection. Despite this concentrated options activity, the overall sentiment for both BX and KRYS, as well as the broader market impact, remains neutral. This suggests that while specific positioning is occurring in the derivatives market, it has not yet translated into a definitive market-wide directional consensus or significant immediate price action.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment